Journal Maturitas Publishes Position Statement on Diet and Health in Midlife and Beyond
Amsterdam, December 11, 2012 – Elsevier, a world-leading provider of scientific, technical and medical information products and services, announced today the publication of a position statement by the European Menopause and Andropause Society (EMAS) in journal Maturitas.
As we live longer, ensuring a healthy diet becomes a growing public health issue. There is increasing evidence that life-style factors, such as nutrition, physical activity, smoking and alcohol consumption have a profound modifying effect on the epidemiology of most major chronic conditions affecting midlife health. Type 2 diabetes mellitus is best prevented or managed by restricting the total amount of carbohydrate in the diet and by deriving carbohydrate energy from whole-grain cereals, fruits and vegetables. Obese elderly people should therefore be encouraged to lose weight. The substitution of saturated and trans-fatty acids by mono-unsaturated and omega-3 fatty acids found in olive oil and oily fish are important dietary interventions for the prevention of cardiovascular disease. Adequate protein, calcium and vitamin D intake should be ensured for the prevention of osteoporotic fractures. A diet rich in vitamin E, folate, B12 and omega-3 fatty acids may be protective against cognitive decline.
The EMAS position statement: ‘Diet and health in midlife and beyond’, by Irene Lambrinoudaki, Iuliana Ceausu, Herman Depypere, Tamer Erel, Margaret Rees, Karin Schenck-Gustafsson, Tommaso Simoncini, Florence Tremollieres, Yvonne van der Schouw, Faustino R. Pérez-López. (10.1016/j.maturitas.2012.10.019) and other papers discussing health in midlife appear in Maturitas Volume 74, Issue 1 (January 2013), published by Elsevier is now available on ScienceDirect.
# # #
Notes to editors
The EMAS position statement and other papers published in the same issue are available to credentialed journalists upon request; contact Greyling Peoples at +31 20 485 3323. firstname.lastname@example.org
About European Menopause and Andropause Society (EMAS)
EMAS promotes the study of midlife health through its journal, congresses, schools and website and encourages the exchange of research and professional experience between members.
Using a range of activities and through its affiliates, EMAS aims to guarantee and provide the same standard of education and information throughout Europe on midlife health in both genders. Recognizing the issues arising from increased longevity the society also provides articles, patient information, web resources, and referrals for healthcare providers in the field and keeps its members up-to-date. For more information go to: http://www.emas-online.org/
Maturitas is an international multidisciplinary peer reviewed scientific journal of midlife health and beyond, publishing original research, reviews, consensus statements and guidelines. The scope encompasses all aspects of postreproductive health in both genders ranging from basic science to health and social care.
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier’s online solutions include ScienceDirect, Scopus, SciVal, Reaxys, ClinicalKey and Mosby’s Suite, which enhance the productivity of science and health professionals, helping research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group plc, a world leading provider of professional information solutions. The group employs more than 30,000 people, including more than 15,000 in North America. Reed Elsevier Group plc is owned equally by two parent companies, Reed Elsevier PLC and Reed Elsevier NV. Their shares are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RUK and ENL.Media contact
+31 20 485 3323